ERP cross-section

ERP by compound

ERP records split by compound, with the index-wide comparison for the same compound beside each one. 27 compounds, 247 records. Cells below n=3 print their raw values instead of a median.

27 compounds247 records

Compound	Class	Reports	ERP median %	Index median %	Δ (pp)	Spec	Pass %
Semaglutide	Incretin	40	98.77	98.87	-0.11	97.0	100
BPC-157	Tissue-repair	33	99.21	99.15	+0.06	98.0	100
TB-500	Tissue-repair	22	99.23	99.47	-0.23	98.5	100
Tirzepatide	Incretin	20	98.64	98.44	+0.20	97.0	95
Ipamorelin	Growth-hormone	15	99.93	99.48	+0.45	99.0	87
Tesamorelin	Growth-hormone	12	98.80	98.43	+0.36	97.0	100
GHK-Cu	Tissue-repair	12	98.49	98.54	-0.05	97.0	100
Semax	Neuroactive	9	99.81	99.17	+0.64	98.5	100
Liraglutide	Incretin	8	98.47	99.02	-0.54	97.5	100
CJC-1295 (no DAC)	Growth-hormone	8	98.89	98.61	+0.28	98.0	100
CJC-1295 with DAC	Growth-hormone	7 n=7	99.52	98.79	+0.73	97.5	100
Mazdutide	Incretin	6 n=6	97.53	98.11	-0.58	96.5	100
Humanin (HNG)	Metabolic	6 n=6	98.88	99.47	-0.59	97.5	100
Kisspeptin-10	Melanocortin-receptor	6 n=6	98.99	99.27	-0.27	98.5	83
Retatrutide	Incretin	5 n=5	98.53	98.41	+0.12	96.5	100
Oxytocin	Hypothalamic	5 n=5	98.82	99.57	-0.75	98.5	100
Pemvidutide	Incretin	5 n=5	98.78	98.41	+0.37	96.0	100
Follistatin-344	Growth-hormone	5 n=5	n<3	—	—	98.0	—
Survodutide	Incretin	4 n=4	98.13	98.69	-0.56	96.5	100
Gonadorelin	Hypothalamic	4 n=4	99.57	99.28	+0.29	98.5	100
PEG-MGF	Growth-hormone	3 n=3	98.08	97.92	+0.16	92.0	100
MOTS-c	Metabolic	3 n=3	98.77	99.18	-0.41	98.0	100
GHRP-6	Growth-hormone	3 n=3	98.97	99.65	-0.68	99.0	33
Glucagon	Incretin	2 n=2	n<3	98.78	—	98.0	50
NAD+	Non-peptide	2 n=2	n<3	98.88	—	97.0	100
Selank	Neuroactive	1 n=1	n<3	99.13	—	99.0	100
MGF	Growth-hormone	1 n=1	n<3	98.73	—	97.5	100

Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.